← Open Payments lookup

BAILEY WULLE: Open Payments

NPI 1518731132 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,768 in 126 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $2,831 · 2025 $2,768

Food & beverage: $2,768
CompanyPaymentsAmount
ABBVIE INC.30$628
Takeda Pharmaceuticals U.S.A., Inc.21$410
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$367
Janssen Biotech, Inc.14$254
Phathom Pharmaceuticals, Inc.6$212
Lilly USA, LLC8$156
GENZYME CORPORATION4$153
Ardelyx, Inc.7$138
Regeneron Healthcare Solutions, Inc.3$95
Gilead Sciences, Inc.5$91

Products named: ENTYVIO, XIFAXAN, RINVOQ, TREMFYA, DUPIXENT, VOQUEZNA, SKYRIZI, OMVOH.

Industry payments across IN — which companies pay providers there.